Browse medicines, page 2 of 6
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Showing 61–120 of 319 records
Parathyroid Hormone (Natpara)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Temporarily relieves discomfort caused by kidney issues, including occasional mild to severe aches, urinary obstruction, intense nausea with or without vomiting, and inability to completely empty the bladder.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE, NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any disease.
Trastuzumab and Hyaluronidase-Oysk (Herceptin Hylecta)
Protein medicineApproved in the United States (FDA)Expanded recordAdalimumab-Aacf (Idacio)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
IDACIO is a tumor necrosis factor (TNF) blocker indicated for: Rheumatoid Arthritis (RA) ( 1.1 ): reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA. Juvenile Idiopathic Arthritis (JIA) ( 1.2 ): reducing signs and symptoms of moderately to severely active polyarticular JIA in patients 2 years of age and older.
Aflibercept-Ayyh (Pavblu)
Protein medicineApproved in the United States (FDA)Expanded recordAmivantamab-Vmjw (Rybrevant)
Protein medicineApproved in the United States (FDA)Expanded recordBenzylpenicilloyl Polylysine (Pre-Pen)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
The assessment of sensitization to penicillin
Bevacizumab-Awwb (Mvasi)
Protein medicineApproved in the United States (FDA)Expanded recordChoriogonadotropin alfa (Ovidrel)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
The induction of final follicular maturation and early luteinization in infertile women who have undergone pituitary desensitization and who
Concizumab-Mtci (Alhemo)
Protein medicineApproved in the United States (FDA)Expanded recordCrizanlizumab-Tmca (Adakveo)
Protein medicineApproved in the United States (FDA)Expanded recordDenosumab-Qbde (Enoby / Xtrenbo)
Protein medicineApproved in the United States (FDA)Expanded recordElapegademase-Lvlr (Revcovi)
Protein medicineApproved in the United States (FDA)Expanded recordFilgrastim-Txid (Nypozi)
Protein medicineApproved in the United States (FDA)Expanded recordGlucarpidase (Voraxaze)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Toxic plasma methotrexate concentration
Golimumab-Sldi (Immgolis / Immgolis Intri)
Protein medicineApproved in the United States (FDA)Expanded recordHyaluronidase (Vitrase / Amphadase / Hydase / Hylenex Recombinant)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Amphadase ® is an endoglycosidase indicated as an adjuvant: • in subcutaneous fluid administration for achieving hydration ( 1.1 ) • to increase absorption and dispersion of other injected drugs ( 1.2 ) • in subcutaneous urography for improving resorption of radiopaque agents ( 1.3 ) 1.1 Subcutaneous Fluid Administration Amphadase ® is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration. 1.2 Dispersion and Absorption of Injected Drugs Amphadase ® is indicated as an adjuvant to increase the dispersion and absorption of other injected drugs.
Hyaluronidase-Nvhy (Opdivo Qvantig)
Protein medicineApproved in the United States (FDA)Expanded recordInfliximab-Qbtx (Ixifi)
Protein medicineApproved in the United States (FDA)Expanded recordInotuzumab Ozogamicin (Besponsa)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia
Insulin Aspart-Fsan (Garzulys)
Protein medicineApproved in the United States (FDA)Expanded recordIslelizumab-Jsgr (Tevimbra)
Protein medicineApproved in the United States (FDA)Expanded recordMargetuximab-Cmkb (Margenza)
Protein medicineApproved in the United States (FDA)Expanded recordRilonacept (Arcalyst)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory Syndrome (FCAS), and Muckle-Wells Syndrome
Sodium Chloride (Sodium Chloride 0.9% in Plastic Container / Natrum Muriaticum / Sodium Chloride 0.45% in Plastic Container / Bacteriostatic Sodium Chloride 0.9% in Plastic Container / Bacteriostatic Sodium Chloride / Resp Ease)
Protein medicineApproved in the United States (FDA)Expanded recordAlbumin Human (Albutein / Plasbumin / Albuked / Flexbumin / Albuminex / Alburx)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
And children
Anifrolumab-Fnia (Saphnelo)
Protein medicineApproved in the United States (FDA)Expanded recordAsfotase alfa (Strensiq)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Perinatal/infantile- and juvenile-onset hypophosphatasia
Asparaginase Erwinia Chrysanthemi -Rywn (Rylaze)
Protein medicineApproved in the United States (FDA)Expanded recordBeractant (Survanta)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants
Bevacizumab-Vikg (Lytenava)
Protein medicineApproved in the United States (FDA)Expanded recordBrolucizumab-Dbll (Beovu)
Protein medicineApproved in the United States (FDA)Expanded recordBulevirtide-Gmod (Hepcludex)
Protein medicineApproved in the United States (FDA)Expanded recordCenegermin-Bkbj (Oxervate)
Protein medicineApproved in the United States (FDA)Expanded recordCipaglucosidase Alfa-Atga (Pombiliti)
Protein medicineApproved in the United States (FDA)Expanded recordClesrovimab-Cfor (Enflonsia)
Protein medicineApproved in the United States (FDA)Expanded recordDenosumab-Mobz (Boncresa / Oziltus)
Protein medicineApproved in the United States (FDA)Expanded recordDonanemab-Azbt (Kisunla)
Protein medicineApproved in the United States (FDA)Expanded recordDostarlimab-Gxly (Jemperli)
Protein medicineApproved in the United States (FDA)Expanded recordEflapegrastim-Xnst (Rolvedon)
Protein medicineApproved in the United States (FDA)Expanded recordEpoetin Alfa-Epbx (Retacrit)
Protein medicineApproved in the United States (FDA)Expanded recordFibrinolysin (Elase-Chloromycetin)
Protein medicineApproved in the United States (FDA)Expanded recordField Mushroom (Mushroom)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
BOTANICAL PURITY FOR A YOUTHFUL COMPLEXION SOOTHES, PROTECTS, AND BALANCES SENSITIVE SKIN It relieves dry, flaky skin and protects against irritation and harmful microbes, restoring balance to your skin.
Ibalizumab-Uiyk (Trogarzo)
Protein medicineApproved in the United States (FDA)Expanded recordIdursulfase (Elaprase)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Hunter syndrome
Imiglucerase (Cerezyme)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Non-central nervous system (CNS) manifestations of Type 1 or Type 3 Gaucher disease
Infliximab-Abda (Renflexis)
Protein medicineApproved in the United States (FDA)Expanded recordInfliximab-Axxq (Avsola)
Protein medicineApproved in the United States (FDA)Expanded recordInsulin Aspart Recombinant (Novolog / Novolog Penfill / Novolog Innolet)
Protein medicineApproved in the United States (FDA)Expanded recordInsulin Aspart-Xjhz (Kirsty)
Protein medicineApproved in the United States (FDA)Expanded recordInsulin Detemir Recombinant (Levemir / Levemir Innolet / Levemir Penfill)
Protein medicineApproved in the United States (FDA)Expanded recordLanadelumab-Flyo (Takhzyro)
Protein medicineApproved in the United States (FDA)Expanded recordLuspatercept-Aamt (Reblozyl)
Protein medicineApproved in the United States (FDA)Expanded recordPyrethrum Extract (Pyrethrum)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Uses Uses treats head lice, pubic (crab) lice, and body lice
Alglucosidase alfa (Lumizyme / Myozyme)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Pompe disease
Amivantamab and Hyaluronidase-Lpuj (Rybrevant Faspro)
Protein medicineApproved in the United States (FDA)Expanded recordAnsuvimab-Zykl (Ebanga)
Protein medicineApproved in the United States (FDA)Expanded recordAprotinin (Trasylol)
Protein medicineApproved in the United States (FDA)Expanded recordAsparaginase (Elspar / Rylaze)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma
Atacicept-Vymj (Trutakna)
Protein medicineApproved in the United States (FDA)Expanded recordAtezolizumab and Hyaluronidase-Tqjs (Tecentriq Hybreza)
Protein medicineApproved in the United States (FDA)Expanded record